THE HYDRA VASCULAR APPROACH
CV-SPARx is delivering a non-implant therapeutic solution for coronary arterial diseases and all vascular related clinical needs. Our technology mitigates the risk of side effects caused by stent maintenance medication and the changes to the quality of life for our patients.
ADDRESSING CLINICAL NEEDS:
Using energy to facilitated drug delivery Hydra Vascular answer the need for NON IMPLANT therapy and is an alternative to vascular stenting and the harmful side effects of implant maintenance medications. Our technology overcomes the challenge of Drug Coated Balloons and Drug Eluting Stents through mode of action and offer a more secure drug delivery and drug residence at the target lesion. Our robust coating lessons the regulatory risks of particulate generation for a wider scope of regulatory and clinical acceptance.
Coronary Artery Disease